高敏肌钙蛋白即时检测在急性诊疗中实施的考量与务实策略
疑似急性冠脉综合征快速风险分层面临肌钙蛋白周转时间长的挑战,全血即时检测(POC)可提供解决方案。国际临床化学与检验医学联合会心脏生物标志物临床应用委员会(IFCC C-CB)制定教育性文件,提供高敏肌钙蛋白POC检测在急性医疗中实施的务实框架,涵盖验证与核实程序及制造商职责。
要点
- POC全血高敏肌钙蛋白检测可缩短周转时间,助力快速风险分层。
- 实施前需平衡适当评估、验证与本地核实,避免重复中心实验室检测工作。
- 文件明确制造商职责并推荐仪器常规使用前的本地核实方法。
核心结论
- IFCC C-CB文件为高敏肌钙蛋白POC检测在急性医疗中实施提供务实框架。
研究设计与样本
- IFCC C-CB制定教育性文件,提供实施建议与验证核实程序。
主要发现
- 全血POC检测可解决肌钙蛋白周转时间长的挑战。
- 缺乏POC仪器评估与部署的共识,需务实策略平衡评估与避免重复工作。
临床怎么用
- 在急性医疗设置和网络中,按文件建议实施高敏肌钙蛋白POC检测。
- 仪器常规使用前应完成本地核实,并明确制造商职责。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A challenge in the implementation of rapid risk-stratification algorithms for patients with suspected acute coronary syndrome is the turnaround time for cardiac troponin (cTn) from blood sampling to reporting of results. Measurement of cTn in whole blood using point of care (POC) offers a solution. There is lack of consensus on how these instruments should be assessed and deployed when implemented into routine practice. A pragmatic strategy is needed to balance the requirement for appropriate evaluation, validation and local verification of POC high sensitivity (hs) cTn assays whilst avoiding unnecessary duplication of previously conducted work using central laboratory assays. The International Federation of Clinical Chemistry and Laboratory Medicine Committee on Clinical Application of Cardiac Bio-Markers (IFCC C-CB) has developed an educational document to provide practical suggestions as to how hs-cTn POC assays may be implemented in acute health care settings and networks. The objective of this document is to provide a pragmatic framework for implementation of such systems. The article describes the validation and verification procedures and outlines what should be the responsibility of the manufacturers and provides recommendations on how a local verification may be undertaken before instruments are implemented into routine clinical practice.
引用
- Collinson P, Lam L, Pickering JW, et al. Considerations and pragmatic strategies for implementation of point of care testing for high sensitivity cardiac troponin into the acute care setting. Clin Chem Lab Med. 2026. PMID: 41784012. doi:10.1515/cclm-2026-0210
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。